Non-Muscle Invasive Bladder Carcinoma — Trials

Non-Muscle Invasive Bladder Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

100 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 55
Recruiting: 35
Ph III recruiting: 8
Growth YoY: —
Industry share: 36%
Top sponsor: Janssen Research & Development, LLC
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07800507	Trop2-Targeted Near-Infrared Fluorescence Imaging-Guided Precise Resection of Non-Muscle Invasive Bladder Cancer	not yet recruiting	Phase 1 / Phase 2	30	Yunnan Cancer HospitalOTHER	1	Sep 24, 2026	clinicaltrials
NCT07725796	A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC	not yet recruiting	Phase 1	30	UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.INDUSTRY	1	Jul 24, 2026